Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bisphosphonates: structure-activity relations from a clinical perspective

S E Papapoulos1

  • 1Department of Endocrinology, University of Leiden Medical Center, The Netherlands.

Medicina
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone material strength index as measured by in vivo impact microindentation is normal in subjects with high-energy trauma fractures.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2022
Same author

Denosumab for the treatment of primary pediatric osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Treatments of osteoporosis increase bone material strength index in patients with low bone mass.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

Bone material strength index as measured by impact microindentation is low in patients with fractures irrespective of fracture site.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

Serum Dickkopf 1 levels in sclerostin deficiency.

The Journal of clinical endocrinology and metabolism·2013
Same author

Long-term treatment of osteoporotic women with bisphosphonates does not impair the response to subsequently administered intravenous pamidronate.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2013
Same journal

Detection of VIM-3 in oral squamous cell carcinomas: methodological limitations.

Medicina·2026
Same journal

The importance of specific antibodies in VIM-3 research: addressing a key methodological flaw.

Medicina·2026
Same journal

[From the right to be cared for to the duty to care: Legal bases for the implementation of palliative care in Argentina].

Medicina·2026
Same journal

[Surrogacy].

Medicina·2026
Same journal

[The misunderstandings in interpreting the "diagnostic superiority of Artificial Intelligence" and the explainable Artificial Intelligence].

Medicina·2026
Same journal

[Artificial intelligence in medicine: between algorithmic opacity and clinical responsibility].

Medicina·2026
See all related articles

Bisphosphonates bind bone mineral and inhibit resorption. Modifications to their structure, particularly the R2 side chain, significantly impact antiresorptive potency, with nitrogen-containing compounds showing enhanced efficacy.

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Biochemistry

Background:

  • Bisphosphonates are synthetic compounds with a P-C-P core and two side chains (R1, R2).
  • They bind bone mineral, inhibit crystal growth, and suppress osteoclast activity.
  • Structural variations allow for diverse pharmacological properties.

Purpose of the Study:

  • To define structure-activity relationships (SAR) of bisphosphonates.
  • To elucidate the molecular mechanism of bisphosphonate action.
  • To guide rational drug design for clinical applications.

Main Methods:

  • Analysis of bisphosphonate chemical structure and its correlation with biological activity.
  • Review of existing literature on bisphosphonate binding and antiresorptive effects.

Related Experiment Videos

  • Investigation of the role of R1 and R2 side chains in bisphosphonate function.

    • Main Results:

    • The P-C-P core and R1 chain (especially with a hydroxyl group) are crucial for bone mineral binding and physicochemical actions.
    • The R2 chain dictates antiresorptive potency; nitrogen-containing R2 groups enhance potency and specificity.
    • Recent findings suggest the entire bisphosphonate molecule is necessary for antiresorptive action.

    Conclusions:

    • Basic structural requirements for bisphosphonate activity are known.
    • Precise SAR are not yet fully defined, hindering mechanistic understanding.
    • Further research is needed for rational design of bisphosphonates for various clinical indications.